规格: | 98% |
分子量: | 461.6 |
包装 | 价格(元) |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
Background:
CDK9-IN-13 (compound 38) is potent and selective CDK9 inhibitor, with an IC50 of<3 nM. CDK9-IN-13 exhibits short half-lives in rodents[1].
[1]. Barlaam B, et, al. Discovery of a Series of 7-Azaindoles as Potent and Highly Selective CDK9 Inhibitors for Transient Target Engagement. J Med Chem. 2021 Oct 28;64(20):15189-15213.
Protocol:
CDK9 <3nM(IC50) | CDK1 0.14μM(IC50) | CDK2 0.72μM(IC50) | CDK7 0.40μM(IC50) | CDK12 0.055μM(IC50) |